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Abstract.
Background: Physical activity (PA) may slow the development of dementia by reducing the accumulation of amyloid.
Objective: We tested the hypothesis that higher levels of leisure-time PA in mid- or late-life were associated with lower brain
amyloid burden in late-life among 326 non-demented participants from the Atherosclerosis Risk in Communities Study of
brain florbetapir positron emission tomography (ARIC-PET) ancillary.
Methods: Self-reported PA was quantified using a past-year recall, interviewer-administered questionnaire in mid-life (1987-
1989, aged 45–64 years) and late-life (2011-2013, aged 67–89 years). Continuous PA estimates were classified as 1) any
leisure-time PA participation (yes/no); 2) meeting the 2018 United States’ PA guidelines (yes/no); and 3) per 1 standard
deviation (SD) higher metabolic equivalent of task (MET) minutes per week (MET·min·wk−1). A brain magnetic resonance
imaging scan with Florbetapir PET was performed in late-life. Adjusted odds ratios (OR) of elevated amyloid burden, defined
as a global cortical standardized uptake value ratio (>1.2), compared to no elevated amyloid burden were estimated according
to PA measures.
Results: Among the 326 participants (mean age: 76 years, 42% male, 41% Black), 52% had elevated brain amyloid burden.
Mid-life leisure-time PA did not show a statistically significant lower odds of elevated late-life amyloid burden (OR = 0.71,
95% CI: 0.43–1.18). A 1 SD (970 MET. min. wk–1) higher PA level in mid-life was also not significantly associated with
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elevated amyloid burden (OR = 0.89, 95% CI: 0.69–1.15). Similar estimates were observed for meeting versus not meeting
PA guidelines in both mid- and late-life.
Conclusion: Self-reported higher mid- and late-life leisure-time PA were not significantly associated with lower amyloid
burden. Data show a trend of an association, which is, however, imprecise, suggesting replication in larger studies.
Keywords: Amyloid, cohort study, epidemiology, imaging, PET, physical activity
INTRODUCTION
Reducing the burden of cognitive impairment in
the United States aging population is a high priority
that may be attainable by intervening on modifi-
able behaviors such as physical activity. Our prior
work in the Atherosclerosis Risk in Communities
(ARIC) Study suggests that compared to participants
who were physically inactive in mid-life (aged 45–64
years), middle or high levels of leisure-time phys-
ical activity were associated with less global and
domain-specific cognitive decline and a lower inci-
dence of dementia over 14 years of follow-up [1]. The
underlying mechanisms that link physical activity to
brain-related outcomes are still unknown but hypoth-
esized to occur through several pathways, including
increased neurogenesis [2] and the reduction of vas-
cular and metabolic risk factors, including blood
pressure [3], blood glucose levels [4], and systemic
inflammation [5].
Mouse models have related physical activity (i.e.,
wheel running) to lower amyloid levels in the brain
[6]. However, the role of exercise on amyloid-
burden in the human brain has not been widely
examined. The results to date appear inconsistent,
and there have been no reports on physical activ-
ity in mid-life at a time when amyloid- begins
to accumulate in the brain [6]. The largest human
investigation thus far to examine this association was
conducted among 268 elderly French community-
dwelling individuals with mild cognitive impairment.
In this cross-sectional analysis, self-reported physical
activity measured continuously was not associated
with brain amyloid burden (Odds Ratio = 1.00, 95%
Confidence Interval: 0.99–1.00), based on Florbe-
tapir levels (defined as a standardized uptake volume
ratio (SUVR)>1.10) [7]. In another cross-sectional
analysis, there was no association between levels of
self-reported physical activity and amyloid positron
emission tomography (PET) among the total sam-
ple of 116 cognitively normal individuals. However,
lower levels of amyloid- were observed in the high-
est versus lowest tertile of self-reported physical
activity, but only among apolipoprotein (APOE) 4
allele carriers [8]. Other prior studies have observed
a significant negative association between physical
activity and amyloid burden measured with PET,
including a report on 60 cognitively normal older
adults showing that participants with elevated amy-
loid had significantly lower reported exercise [9].
An additional report of 317 middle-aged adults from
the Wisconsin Registry for Alzheimer’s Prevention
found that self-reported physical activity attenuated
the adverse effects of age on amyloid burden [10].
Altogether, the current literature on the association
between physical activity and brain amyloid burden is
constrained by small sample sizes and cross-sectional
assessments which are susceptible to a reverse causa-
tion interpretation. A further limitation is the lack of
repeated measures of physical activity. Considering
the variation in physical activity over the adult life
span associated with changes in lifestyle and func-
tional abilities, a one-time measurement of physical
activity may not be a reliable or informative evalua-
tion of an individual’s activity exposure. Considering
the fact that amyloid deposition occurs decades prior
to manifest clinical symptoms, quantifying physical
activity levels across life epochs with repeated mea-
sures is imperative.
Therefore, we examined the association between
leisure-time physical activity and PET-quantified
brain amyloid burden in the ARIC cohort by
incorporating both late-life and repeated mid-life
assessments of physical activity with more than 25
years of follow-up. We also examined whether the
associations differed by APOE ε4 carrier allele status,
race-study center, and cognitive status. We hypoth-
esized that higher levels of leisure-time physical
activity in mid- or late-life were associated with lower
brain amyloid burden in late-life.
MATERIALS AND METHODS
Study population and design
Participants for the ARIC-PET ancillary were
recruited from the ongoing ARIC cohort, a
community-based prospective study. Enrollment for
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ARIC began in 1987 with 15,792 participants aged
45–64 years recruited from four U.S. communi-
ties (Washington County, Maryland; Forsyth County,
North Carolina; selected suburbs of Minneapolis,
Minnesota; and Jackson, Mississippi). The baseline
ARIC visit (1987-1989) was followed by three tri-
ennial visits (visit 2 : 1990-1992, visit 3 : 1993-1995,
visit 4 : 1996-1998), and a fifth visit occurring 15
years later in 2011-2013. Details about the cohort
have been described [11]. Among those participants
who returned for the fifth examination (n = 6,538;
2011-2013), approximately 2,000 were selected to
undergo a brain magnetic resonance imaging (MRI)
scan, which included both participants with cogni-
tive impairment and an age-stratified sample without
impairment [12]. Among participants who received
a brain MRI, recruitment for the ARIC-PET ancil-
lary included those participants without dementia,
heavy current alcohol use, renal dysfunction (crea-
tinine > 2mg/dL), or prolonged QT-c interval (>450
ms) from three of the ARIC sites (Forsyth County,
NC; Jackson, MS; and Washington County, MD). Of
those participants recruited in ARIC-PET (n = 346),
we excluded participants who were non-Black or
non-White (n = 2); had a dementia diagnosis (n = 1);
missing APOE 4 (n = 4); or missing physical activity
measurements at visits 1, 3, or 5 (n = 13). Our final
analytic sample included 326 adults with measures
of amyloid burden and physical activity measured
in both mid-life and late-life. ARIC-PET ancillary
study protocols and procedures were approved by
the Institutional review boards at each participating
study center. All participants gave written informed
consent.
Exposure: Leisure-time Physical Activity (LTPA)
LTPA was measured at ARIC visits 1, 3, and 5
using the modified Baecke Physical Activity Ques-
tionnaire, a standardized interviewer administered
questionnaire that utilizes a past-year recall time
frame [13]. For the sports and leisure domain, the
questionnaire asked, in open-ended form, for up to
four of the most common sports or leisure-time types.
For each activity type, information related to the
duration (hours per week) and frequency (number of
weeks per month) were collected. While the Baecke
Questionnaire scoring of summary estimates results
in index scores for sport, leisure, and work rang-
ing from 1 to 5 (reflecting the highest activity level)
[13], several questions from the sports domain were
rescored and summarized as metabolic equivalent of
task (MET) minutes per week (MET·min·wk−1). This
was used because it provides a physiologically mean-
ingful estimate that can be compared to other studies
and extrapolated to reflect meeting (or not meeting)
public health recommendations for physical activity.
For this, each activity type was assigned a MET
value ranging from 1–12 METs based on the 2011
Compendium of Physical Activities [14]. For each
activity type reported, MET·min·wk−1 was estimated
over the past year by multiplying the frequency, dura-
tion, and MET value, and were summed across all
activity types reported (up to four) to quantify total
volume of LTPA. Participants who reported that they
did not participate in any sports or leisure-time activ-
ities were assigned a value of 0 MET·min·wk−1.
LTPA, in minutes per week (min·wk−1), was also
categorized according to the 2018 US Physical Activ-
ity Guidelines of at least 150 minutes of aerobic
moderate or vigorous intensity per week, with inten-
sity based on reported activities of at least 3 METS
[15]. For this study, physical activity was operational-
ized in mid-life (visit 1) and late-life (visit 5) as:
1) participation in LTPA (yes/no); 2) meeting 2018
physical activity guidelines (yes/no); and 3) per 1
standard deviation (SD; 970 MET·min·wk−1) higher
total MET·min·wk−1. We also averaged the total
MET·min·wk−1 in mid-life at visits 1 and 3 (1993-
1995) to obtain an overall measure of total volume of
LTPA across 6 years in mid-life.
The Baecke questionnaire has moderate to
good reliability (test-retest reliability ranging from
0.74–0.88) [13]. The questionnaire has also been
shown to have moderate validity (Spearman corre-
lation coefficient = 0.54) against energy expenditure
measured with doubly-labeled water [16].
Outcome: Elevated amyloid burden
Brain MRIs were obtained from a 3T MRI scan
in late-life at visit 5/ARIC-Neurocognitive Study
(NCS) (2011-2013) [12]. Florbetapir PET scans
were performed within 1 year of the brain MRI
scan with magnetization-prepared rapid gradient
echo (MPRAGE) used for coregistration of the PET
images. Isotopes were injected 50–70 min before a
20 min uptake scan. Each image was reviewed for
incidental findings, image quality, and quantified
for SUVRs. SUVRs were obtained for each of the
34 total regions of interest, but the primary analy-
sis used the global cortical measure of amyloid-,
calculated as the weighted average of the follow-
ing regions: orbitofrontal, prefrontal, and superior
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frontal cortices, lateral temporal, parietal, and occip-
ital lobes, precuneus, and anterior and posterior
cingulates. The primary outcome was global amyloid
SUVR dichotomized at the analytic sample median
(SUVR > 1.2) to indicate elevated brain amyloid bur-
den. The value of 1.2 was chosen due to the highly
skewed distribution of the data and is in line with prior
ARIC-PET studies [17–19]. Note that this value does
not correspond to others in the literature on elevated
amyloid levels by PET [20]. In sensitivity analyses,
we also examined global amyloid SUVR continu-
ously and using an alternate cutpoint >1.3 (n = 103
(31.6%)) to more accurately reflect elevated amyloid
burden in a general population.
Covariates
Covariates include age, sex, education (less than
high school, high school or equivalent, and greater
than high school), race-ARIC field center (White
adults from Minneapolis, Washington County, or
Forsyth County or Black adults from Forsyth County
and Jackson) to reflect the race-geographic distribu-
tion of the ARIC cohort, and APOE 4 genotype (0
or ≥1 allele). All covariates, except age which ref-
erences the time of the physical activity exposure
assessment, were assessed at the mid-life base-
line ARIC visit 1 (1987-1989). Additional analyses
considered adjustment for intermediate cardiovas-
cular and lifestyle risk factors measured at the
time of the ARIC-PET ancillary study (2011-2013):
type 2 diabetes mellitus (defined as fasting glucose
≥126 mg/dL or ≥200 mg/dL non-fasting glucose,
self-reported history of physician-diagnosed dia-
betes, or use of diabetes mellitus medication);
hypertension (defined as systolic blood pressure
≥140 mmHg, diastolic blood pressure ≥90 mmHg,
or use of blood pressure-lowering medication); and
body mass index (BMI, calculated as measured
weight in kilograms divided by height in meters
squared) [21].
Statistical analysis
Descriptive analysis used chi-square and ANOVA
tests to examine differences in baseline sociodemo-
graphic and disease characteristics among partici-
pants who did and did not participate in LTPA in
mid-life (visit 1). Multivariable logistic regression
was used to estimate the cross-sectional associa-
tions of LTPA operationalized in mid-life (visit 1)
and late-life (visit 5) as: 1) participation in LTPA
(yes/no); 2) meeting 2018 physical activity guide-
lines (yes/no); and 3) per 1 standard deviation (SD)
higher total MET·min·wk−1, with elevated amyloid
burden in late-life. Multivariable linear regression
was used to estimate the cross-sectional associations
of LTPA measures with continuous global amyloid
SUVR in late-life. We also examined the associa-
tions using LTPA as an average across visits 1 and
3 in mid-life. Sensitivity analyses explored elevated
amyloid burden at an SUVR cutpoint >1.3. Models
were adjusted for age at time of LTPA assessment,
sex, education, race-ARIC field center interaction,
and APOE ε4. Additional models further adjusted for
visit 5 measures of BMI, hypertension, and diabetes
as confounders. We also explored for effect modifi-
cation by race-study center, APOE 4 carrier allele
status, and cognitive status (normal versus mild cog-
nitive impairment) with inclusion of interaction terms
for the exposure and proposed modifier in the model.
Stata version 15.0 was used for all analyses (Stata-
Corp LLC, College Station, TX, USA).
RESULTS
Sociodemographic and clinical characteristics of
the study population (n = 326) are provided in Table 1
overall and by reported participation (yes/no) in
LTPA in mid-life (visit 1, 1987-1989). Participants
who did not participate in LTPA were more often
Black and female and had lower educational attain-
ment. Participants not reporting LTPA also had a
worse cardiometabolic risk factor profile, includ-
ing, a slightly higher prevalence of hypertension and
smoking and a somewhat higher BMI. Our data sug-
gest a medium/moderate correlation (0.33–0.45) of
physical activity (in MET·min·wk−1) across ARIC
visits from mid- to late-life [22]. The frequency
of elevated amyloid burden (global SUVR > 1.2)
was also higher in participants who did not par-
ticipate in LTPA. Figure 1 shows the negative
linear relationship between total volume of LTPA
(MET·min·wk−1) in mid-life and global SUVR in
late-life. At the median SUVR cutoff of 1.2, par-
ticipants with non-elevated amyloid burden (SUVR
≤1.2) in late-life had on average higher total LTPA
in mid-life (381.3 MET·min·wk−1) compared to par-
ticipants with elevated amyloid burden (SUVR > 1.2)
in late-life (270.4 MET·min·wk−1).
The prevalence of SUVR > 1.2 in late-life in
the analytic sample was 52% (n = 169; Table 1).
Participation in LTPA in mid-life was not signifi-
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Table 1
Participant characteristics overall and by participation in leisure-time physical activity in mid-life (Visit 1, 1987-1989), n = 326
Participant characteristics Participation in
physical activity
Total No Yes
(n = 326) (n = 126) (n = 200)
Age, y, mean (SD) 52.3 (5.2) 52.1 (4.9) 52.4 (5.4)
Female sex*, n (%) 187 (57.4) 84 (66.7) 103 (51.5)
Black race*, n (%) 135 (41.4) 68 (54.0) 67 (33.5)
APOE ε4
0 allele, n (%) 224 (68.7) 84 (66.7) 140 (70.0)
1 allele, n (%) 94 (28.8) 39 (31.0) 55 (27.5)
2 allele, n (%) 8 (2.5) 3 (2.4) 5 (2.5)
<High school education*, n (%) 52 (16.0) 26 (20.6) 26 (13.0)
Current smoker, n (%) 57 (17.5) 24 (19.0) 33 (16.5)
Hypertension*, n (%) 95 (29.3) 41 (32.8) 54 (27.1)
Diabetes*, n (%) 18 (5.5) 8 (6.4) 10 (5.0)
Body Mass Index*, kg/m2, mean (SD) 29.0 (5.4) 30.1 (5.9) 28.3 (4.9)
Late-life Cognitive Status
Normal, n (%) 239 (73.3) 92 (73.0) 147 (73.5)
Mild cognitive impairment, n (%) 87 (26.7) 34 (27.0) 53 (26.5)
Mid-life Meeting PA guidelines*, n (%) 101 (31.0) 0 (0.0) 101 (50.5)
Mid-life MET. min. wk–1*, mean (SD) 572.4 (750.9) 0 (0.0) 933.0 (763.4)
Late-life Participation in PA*, n (%) 224 (68.7) 69 (54.8) 155 (77.5)
Late-life Meeting PA guidelines*, n (%) 146 (44.8) 38 (30.2) 108 (54.0)
Late-life MET. min. wk–1*, mean (SD) 667.0 (738.4) 454.2 (623.8) 801.1 (774.1)
Late-life Global SUVR, mean (SD) 1.30 (0.26) 1.32 (0.26) 1.28 (0.26)
Late-life Elevated amyloid burden (SUVR > 1.2)*, n (%) 169 (51.8) 75 (59.5) 94 (47.0)
*p < 0.05 for differences between participation in physical activity (yes/no). Characteristics are measured at mid-life (visit 1, 1987-1989)
unless specified. SD, standard deviation; SUVR, standardized uptake value ratio; PA, physical activity. Mid-life, Visit 1 (1987-1989);
Late-Life, Visit 5 (2011-2013).
Fig. 1. Scatterplot of mid-life (visit 1) total leisure-time physical
activity in MET·min·wk−1 and global standardized uptake value
ratio measured in late-life (visit 5). SUVR, standardized uptake
value ratio.
cantly associated with a lower prevalence of elevated
amyloid burden (Odds ratio [OR] = 0.71 (95% con-
fidence interval [CI]: 0.43, 1.18)) compared to
non-participation in LTPA in mid-life (Fig. 2). The
OR of elevated amyloid burden for those who met
the 2018 U.S. Physical Activity Guidelines in mid-
life was 0.83 (95% CI: 0.49, 1.42) compared to those
who did not meet the guidelines in mid-life. A per
standard deviation (SD) higher total volume of LTPA
(970 MET·min·wk−1) in mid-life was also not signif-
icantly associated with an elevated amyloid burden
OR = 0.89 (95% CI: 0.69, 1.15) in late-life, although
each point estimate favored an inverse association
between physical activity and amyloid burden. No
significant associations were observed for all mea-
sures of LTPA in mid- and late-life with global
amyloid SUVR analyzed continuously (Table 2) or
when using a more conservative global amyloid
SUVR cut point >1.3. Specifically, the OR of ele-
vated amyloid burden (based on an SUVR cut point
>1.3) for participation in LTPA in mid-life compared
to non-participation in LTPA in mid-life was 0.77
(95% CI: 0.44, 1.33).
An overall measure of total volume of LTPA
in mid-life was estimated by averaging the
MET·min·wk−1 at visits 1 and 3. Results were similar
to those observed with total volume of LTPA mea-
sured at visit 1 only (data not shown). In summary,
regardless of how LTPA was operationalized, mid-life
LTPA was not significantly associated with amyloid
burden in late- life. For all models considering either
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Fig. 2. Adjusted odds ratio (OR) and 95% confidence interval of elevated brain amyloid burden (standardized uptake value ratio (SUVR) > 1.2)
by measures of leisure-time physical activity (LTPA) in mid- and late-life. Models for mid-life and late-life leisure-time physical activity
were run separately. *1 standard deviation (SD) = 970 MET·min·wk−1.
Table 2
Adjusted association of measures of leisure-time physical activity in mid- and late-life with continuous




Participation in Physical Activity (yes versus no) –0.02 (–0.08, 0.03) 0.406
Meeting physical activity guidelines (yes versus no) –0.04 (–0.10, 0.02) 0.187
Per 1 SD Higher Physical Activity –0.01 (–0.04, 0.01) 0.297
LATE-LIFE PHYSICAL ACTIVITY
Participation in Physical Activity (yes versus no) 0.03 (–0.03, 0.09) 0.316
Meeting physical activity guidelines (yes versus no) 0.03 (–0.03, 0.08) 0.285
Per 1 SD Higher Physical Activity 0.01 (–0.02, 0.03) 0.720
Models adjusted for age, sex, education, race-center, APOE ε4. *p < 0.05. SUVR, standardized uptake value
ratio; SD, standard deviation.
mid- or late-life LTPA, we did not observe any sig-
nificant interactions by race, APOE 4, or cognitive
status. Although results were slightly attenuated, the
overall inferences were also not affected by additional
adjustment for BMI, diabetes, and hypertension (data
not shown).
DISCUSSION
In this largest known community-based sample of
non-demented older adults with amyloid imaging and
repeated measures of LTPA, neither mid- nor late-life
LTPA was statistically significantly associated with
brain amyloid burden. Our findings fail to support our
a priori hypothesis that a mid-life measure of LTPA,
free of any question of reverse causality, is signifi-
cantly associated with brain amyloid burden 25 years
later. This result is important because it shows the
troublesome independence of amyloid accumulation
from the healthy behavior of physical activity.
Our study adds new evidence to the literature
relating physical activity to brain amyloid. Although
previous findings from human studies have been
inconsistent, rodent studies have consistently shown
lower brain amyloid burden after intense exercise.
Our lack of significant associations is consistent with
those of the largest human study to date, based
on 268 mild cognitively impaired participants with
PET-quantified amyloid- and self-reported phys-
ical activity [7]. This largest study to date raises
potential concerns pertaining to its more cognitively
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impaired participant population, because the cogni-
tive impairment might both affect habitual physical
activity levels and reduce the accuracy of reported
physical activity. However, the results of studies
limited to cognitively normal participants have also
been conflicting. In an investigation of 85 late-
middle-aged adults from the Wisconsin Registry for
Alzheimer’s Prevention, moderate intensity physi-
cal activity, ascertained with 1-week actigraphy, was
inversely associated with cerebrospinal fluid mea-
sured amyloid- [23]. In contrast, in a study of 139
cognitively normal participants, self-reported phys-
ical activity was not associated with cerebrospinal
fluid measured amyloid- in the Dominantly Inher-
ited Alzheimer Network [24]. Using PET-quantified
amyloid imaging, the data among cognitively normal
participants has also been inconsistent, with some
reports showing that higher levels of self-reported
physical activity are associated with lower levels of
amyloid burden [8–10, 25]. Conversely, data from
182 clinically normal older adults enrolled in the
Harvard Aging Brain Study did not show a statisti-
cally significant cross-sectional association between
accelerometer-measured physical activity and amy-
loid burden after adjusting for age and sex [26].
Interpretation of these studies, however, is clouded
by the fact that they relate amyloid burden with con-
current levels of physical activity, possibly indicating
an effect rather than a cause of the amyloid burden.
There are limitations to the present study. The
exposure assessment relied on self-report, which typ-
ically overestimates vigorous physical activity and
underestimates and/or does not quantify light phys-
ical activity [27]. This supports the need for studies
to also include device-based assessments of physical
activity into data collection protocols. The criteria by
which participants were selected for the ARIC-PET
study may constrain generalizability. Specifically,
participants enrolled in PET studies are those will-
ing and able to tolerate the MRI and PET scans, and
therefore may be potentially healthier. Lastly, though
the results show a consistent, but not statistically sig-
nificant, protective association of physical activity on
amyloid burden, our study’s size potentially limits its
power to detect small differences. A post-hoc power
analysis conducted in G*Power 3.1 suggests that for
an OR = 0.71 for elevated amyloid burden comparing
participants who participate versus do not participate
in physical activity, a larger sample size (n > 336) is
required to detect a significant association at 80%
or greater power and an alpha = 0.05. Another limi-
tation of this analysis is that the outcome cut point
was based on a median split of global amyloid PET
SUVR which almost certainly includes persons with
amyloid burdens that are closer to background lev-
els than to levels that are more concerning. Thus, the
elevated amyloid group will contain persons who are
not destined to develop overt Alzheimer’s disease.
This may have made it more difficult to detect an
association with physical activity. However, the same
inferences were supported with a more conservative
SUVR cutpoint >1.3 conducted in sensitivity anal-
yses. Several strengths should be mentioned. First,
the well-characterized ARIC cohort provides over 25
years of collected data, allowing us to examine the
role of physical activity across different life epochs
on brain amyloid in older adulthood. Second, the
cross-temporal analysis (mid-life exposure and late-
life outcome) results provide much clearer results
than those seen at late-life only due to the potential
effects of reverse causation. Lastly, this is the largest
known sample of non-demented older adults with
amyloid imaging and repeat measures of physical
activity.
Given our large sample size, we can reason-
ably conclude that while the point estimates favored
an inverse association of LTPA and brain amyloid
burden, the hypothesized association was not sup-
ported. Although we found that physical activity
is not associated with Alzheimer’s disease pathol-
ogy, it is possible that physical activity is related to
cerebrovascular disease, which has important con-
tributions for later life cognitive impairment. It has
been documented that physical activity can reduce
the risk of diabetes [4], hypertension [3], and obe-
sity [28]. Reductions in these vascular risk factors
may reduce the burden of cerebral atherosclerosis and
arteriolosclerosis and subsequently reduce ischemic
cerebrovascular pathology [29]. In this setting of
less cerebrovascular pathology, individuals may be
more tolerable to higher burdens of Alzheimer’s dis-
ease pathology. Therefore, it is important that future
studies quantify the role of physical activity and its
changes over time with measures of cerebrovascular
disease.
The long-term impact of mid-life leisure-time
physical activity as a modifiable element of lifestyle
is of considerable interest, both in clinical settings
and from a public health perspective. Pharmaceuti-
cal therapies aimed at targeting clinical symptoms
of AD and underlying AD pathophysiological pro-
cesses have not been shown to be effective thus far.
Therefore, there is a greater need to understand how
lifestyle interventions may not only affect AD symp-
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toms but its pathophysiology as well. Randomized
clinical trials of a physical activity lifestyle inter-
vention have not shown clear benefits [30–32], and
implementing sustained modification of long-term
physical activity patterns has proved to be challeng-
ing. This is particularly important in the context of
amyloid- accumulation, which is known to progress
for decades prior to the appearance of clinical
manifestations. Therefore, observational data with
prolonged follow-up, and repeated measures of phys-
ical activity that are preferably objectively-measured,
are still needed to help elucidate the potentially bene-
ficial long-term role of higher physical activity levels
in reducing or slowing the accumulation of brain
amyloid in adulthood.
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